Mirae Asset Global ETFs Holdings
AVIR icon

Mirae Asset Global ETFs Holdings’s Atea Pharmaceuticals AVIR Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio AVIR Stock Details AVIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$182K Buy
33,751
+776
+2% +$3.56K ﹤0.01% 2411
2025
Q4 		$118K Sell
32,975
-2,998
-8% -$9.53K ﹤0.01% 2599
2025
Q3 		$104K Sell
35,973
-5,984
-14% -$20.4K ﹤0.01% 2632
2025
Q2 		$151K Sell
41,957
-4,135
-9% -$12.3K ﹤0.01% 2414
2025
Q1 		$138K Buy
46,092
+1,950
+4% +$6.09K ﹤0.01% 2489
2024
Q4 		$148K Buy
44,142
+1,900
+4% +$6.31K ﹤0.01% 2541
2024
Q3 		$142K Buy
42,242
+3,194
+8% +$11.6K ﹤0.01% 2540
2024
Q2 		$129K Buy
+39,048
New +$146K ﹤0.01% 2459

Other funds holding AVIR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's AVIR Position: Q1 2026 in Review

Mirae Asset Global ETFs Holdings increased its Atea Pharmaceuticals (AVIR) stake by 2.4% in Q1 2026, buying an estimated $3.56K and bringing the position to 33,751 shares worth $182K. The position accounts for ﹤0.01% of the portfolio, ranked #2411.

Mirae Asset Global ETFs Holdings first reported a position in AVIR in Q2 2024 and has held it in 8 quarters since. 127 funds tracked by Wall St. Rank hold AVIR as of Q1 2026.

  • Mirae Asset Global ETFs Holdings held 33,751 shares of Atea Pharmaceuticals worth $182K as of Q1 2026.
  • Mirae Asset Global ETFs Holdings bought 776 Atea Pharmaceuticals shares in Q1 2026, an estimated $3.56K.
  • Atea Pharmaceuticals made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q1 2026, its #2411 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Atea Pharmaceuticals in Q2 2024 and has held it in 8 quarters since.
  • 127 funds tracked by Wall St. Rank held Atea Pharmaceuticals as of Q1 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q1 2026, filed 15 May 2026.